Anthem Biosciences Makes a Splash: 3% Share Surge Post-IPO – Is Now the Time to Invest?

Anthem Biosciences shares surged 3.3% post-IPO debut, with a 27% premium over its IPO price. Experts suggest a 'HOLD' strategy for long-term investors, citing strong fundamentals a...